Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Kioson Komersial Indonesia Tbk (KIOS) Price & Performance

Indofarma Tbk.Trade
Kioson Komersial Indonesia TbkTrade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Kioson Komersial Indonesia Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Kioson Komersial Indonesia Tbk trades at Rp99 (market cap 110.81B, 29.99M 24h volume). The key difference: Indofarma Tbk. is far larger — about 3.5× Kioson Komersial Indonesia Tbk's market cap. Which is the better fit depends on your goals.

INAFKIOS
Market Cap
390.51B110.81B
Volume
29.99M
Lot
299.94K
Turnover
2.97B
Average Price
99
Value
2.97B
Indicative Equilibrium Price
99
Indicative Equilibrium Volume
3.34K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
KIOS
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Kioson Komersial Indonesia Tbk

PT Kioson Komersial Indonesia Tbk (the Company), was established on June 29, 2015 based on Notarial Deed No. 55 of Rose Takarina, S.H.

Read more on KIOS